Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Shares Outstanding (Entity) (2012 - 2026)

Updated

Vistagen Therapeutics' Shares Outstanding (Entity) was 46.19 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 16.9% from 39.5 million a year earlier and up 4.1% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Shares Outstanding (Entity) (2012 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Shares Outstanding (Entity) at Vistagen Therapeutics came in at 41.03 million, up 40.7% from FY2025.

  • Shares Outstanding (Entity) has now increased for 12 consecutive fiscal years, with a five-year compound annual growth rate of 70.2% (FY2021 to FY2026).
  • In earlier fiscal years, Shares Outstanding (Entity) was 29.16 million in FY2025 (+50.7%), 19.35 million in FY2024 (+145.9%), 7.87 million in FY2023 (+14.3%) and 6.89 million in FY2022 (+140.0%).
  • The fiscal Q2 2027 figure marks the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q1 2013.
  • Compared with a year earlier, Shares Outstanding (Entity) has increased for 47 straight quarters, with growth averaging 31.5% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.2% (fiscal Q3 2023) and 291.6% (fiscal Q3 2024) over the last five years.
  • Per Business Quant data, VTGN's Shares Outstanding (Entity) in the three fiscal quarters before Q2 2027 was 44.38 million (Q1 2027), 41.03 million (Q4 2026) and 39.62 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 940.75 Mn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 2.41 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 1.77 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 2.47 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 540.90 Mn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 1.24 Bn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - 46.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 46.19 Mn
Jun 30, 2026 44.38 Mn
Mar 31, 2026 41.03 Mn
Dec 31, 2025 39.62 Mn
Sep 30, 2025 39.50 Mn
Jun 30, 2025 30.68 Mn
Mar 31, 2025 29.16 Mn
Dec 31, 2024 28.86 Mn
Sep 30, 2024 27.84 Mn
Jun 30, 2024 27.06 Mn
Mar 31, 2024 19.35 Mn
Dec 31, 2023 27.03 Mn
Sep 30, 2023 10.04 Mn
Jun 30, 2023 7.38 Mn
Mar 31, 2023 7.87 Mn
Dec 31, 2022 6.90 Mn
Sep 30, 2022 6.90 Mn
Jun 30, 2022 6.90 Mn
Mar 31, 2022 6.89 Mn
Dec 31, 2021 6.74 Mn
API Access

Vistagen Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=VTGN&period=max&api_key=YOUR_API_KEY